Does Diabetes Always Confer Coronary Heart Disease Risk Equivalent to a Prior Myocardial Infarction?

March 2011
Diabetes Care;Mar2011, Vol. 34 Issue 3, p782
Academic Journal
The article discusses the analogy drawn between diabetes and coronary heart disease (CHD) that makes it apparent that CHD risk is elevated in diabetes. It mentions that interpretation of risk information has been shown to be inconsistent. The article also details the 2010 American Diabetes Association (ADA) position statement on aspirin use and a 1998 study by the team of S. M. Haffner which concluded that the elevation risk for diabetic patients was essentially similar to non-diabetic individuals with a prior myocardial infarction.


Related Articles

  • Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. Riche, Daniel M.; McClendon, Katie S. // American Journal of Health-System Pharmacy;8/1/2007, Vol. 64 Issue 15, p1603 

    Purpose. The major statin trials that included a significant number of patients with diabetes without preexisting coronary heart disease (CHD) are reviewed and evaluated, and the role statins should play in primary prevention is discussed. Summary. Cardiovascular (CV) disease risk is increased...

  • Aspirin and Mortality in Patients With Diabetes Sustaining Acute Coronary Syndrome. Cubbon, Richard M.; Gale, Christopher P.; Rajwani, Adil; Abbas, Afroze; Morrell, Christine; Das, Raj; Barth, Julian H.; Grant, Peter J.; Hall, Alistair S.; Kearney, Mark T. // Diabetes Care;Feb2008, Vol. 31 Issue 2, p363 

    OBJECTIVE -- We sought to compare mortality reduction associated with secondary prevention in patients with and without diabetes after acute coronary syndrome (ACS). RESEARCH DESIGN AND METHODS -- We conducted a cohort study involving 2,499 patients with ACS recruited from 11 U.K. hospitals....

  • Management of Dyslipidemia in Adults With Diabetes.  // Diabetes Care;Jan2003 Supplement, Vol. 26, pS83 

    Presents the 2003 position statement of the American Diabetes Association on management of dyslipidemia in adults with diabetes. Lipoprotein risk factors for coronary heart disease; Clinical trials of lipid lowering in diabetic subjects; Modification of lipoproteins by medical nutrition therapy...

  • Rosiglitazone and MI risk - will we ever know the answer?  // Reactions Weekly;6/30/2007, Issue 1158, p3 

    The article reports that recent concerns with rosiglitazone were discussed during a special session at the meeting of the American Diabetes Association. During the opening discussion, a review of the evidence regarding the suggested association between rosiglitazone and an increase in myocardial...

  • Diabetes group recommends low-dose aspirin for cardioprotection. Colwell, John // Modern Medicine;Jan98, Vol. 66 Issue 1, p15 

    Discusses the abstract of the article `American Diabetes Association. Aspirin therapy in diabetes,' which appeared in the November 1997 issue of `Diabetes Care.'

  • Aspirin Therapy in Diabetes.  // Diabetes Care;Jan2003 Supplement, Vol. 26, pS87 

    Presents the 2003 position statement of the American Diabetes Association on aspirin therapy in diabetes. Efficacy; Safety; Dosage; Special recommendations.

  • The Effect of Aspirin Dosing on Platelet Function in Diabetic and Nondiabetic Patients. DiChiara, Joseph; Bliden, Kevin P.; Tantry, Udaya S.; Hamed, Miruais S.; Antonino, Mark J.; Suarez, Thomas A.; Bailon, Oscar; Singla, Anand; Gurbel, Paul A. // Diabetes;Dec2007, Vol. 56 Issue 12, p3014 

    OBJECTIVE-- Diabetic patients may have a higher prevalence of platelet aspirin resistance than nondiabetic patients. Our goal was to analyze platelet aspirin responsiveness to various aspirin doses in diabetic and nondiabetic patients. RESEARCH DESIGN AND METHODS-- We examined the effect of...

  • Coffee not bad after all.  // New Zealand Doctor;5/17/2006, p26 

    The article provides information on the results of a U.S. research on coffee. It was found that drinking more than six cups of coffee a day do not add the risk of coronary heart disease. It also showed that coffee has no bad effects on people with type 2 diabetes. It is said that coffee drinkers...

  • Picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial disease.  // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p61 

    This article cites a medical study which reports that picotamide reduced all-cause mortality more than aspirin in type 2 diabetes mellitus and peripheral arterial disease. The study found that secondary outcomes were the composite endpoint of death and nonfatal cardiovascular events (myocardial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics